Literature DB >> 22017700

Endoscopic therapies for the prevention and treatment of early esophageal neoplasia.

Susi Green1, Pradeep Bhandari, John DeCaestecker, Hugh Barr, Krish Ragunath, Janusz Jankowski, Rajvinder Singh, Gaius Longcroft-Wheaton, Cathy Bennett.   

Abstract

Esophageal cancers have traditionally been diagnosed late and prognosis has been dire. For many years the only real treatment option was esophagectomy with substantial morbidity and mortality. This situation has now changed dramatically. Improvements have been achieved in surgical outcomes and there is an array of new effective treatment options now available, particularly for the increasing proportion diagnosed with early-stage disease. Minimally invasive endoscopic therapies can now prevent, cure or palliate esophageal cancers. This article aims to investigate the role and evidence base for these new therapeutic options.

Entities:  

Mesh:

Year:  2011        PMID: 22017700     DOI: 10.1586/egh.11.80

Source DB:  PubMed          Journal:  Expert Rev Gastroenterol Hepatol        ISSN: 1747-4124            Impact factor:   3.869


  3 in total

1.  Surgery versus radical endotherapies for early cancer and high-grade dysplasia in Barrett's oesophagus.

Authors:  Cathy Bennett; Susi Green; John DeCaestecker; Max Almond; Hugh Barr; Pradeep Bhandari; Krish Ragunath; Rajvinder Singh; Janusz Jankowski
Journal:  Cochrane Database Syst Rev       Date:  2020-05-22

Review 2.  Managing the changing burden of cancer in Asia.

Authors:  Rengaswamy Sankaranarayanan; Kunnambath Ramadas; You-lin Qiao
Journal:  BMC Med       Date:  2014-01-08       Impact factor: 8.775

3.  Genome wide copy number analyses of superficial esophageal squamous cell carcinoma with and without metastasis.

Authors:  Pengjiao Wang; Ling Shan; Liyan Xue; Bo Zheng; Jianming Ying; Ning Lu
Journal:  Oncotarget       Date:  2017-01-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.